(Press-News.org) San Diego—Researchers at the University of California-San Diego School of Medicine have shown that G protein-coupled receptor expression may predict the prognosis of patients with chronic lymphocytic leukemia. Their findings may identify new ways to treat such patients. The UCSD researchers, led by Paul A. Insel, M.D., Professor of Pharmacology and Medicine, will present their findings on April 24.
A clinical problem for many diseases, including chronic lymphocytic leukemia (CLL) the most common form of leukemia in adults, is the lack of tests or biomarkers that can predict its prognosis. The American Cancer Society estimates that about 16,060 new cases of CLL and nearly 4,580 deaths from CLL will occur in 2012. CLL is characterized by an increased accumulation of certain types of malignant while blood cells in the blood stream and is classified as two types: aggressive, which requires immediate treatment; or indolent, which is slow growing and does not require treatment.
Certain tests exist to help predict which type of CLL a patient may have, but the availability and usefulness of such tests are limited. Using white blood cells obtained from patients with indolent or aggressive CLL as well as from healthy individuals, the researchers identified a number of specific G protein-coupled receptors (GPCRs) that are uniquely expressed in patients with two different forms of the disease.
GPCRs are a large family of protein receptors that sense molecules outside of cells and alter pathways and responses within cells. "The expression of particular GPCRs is disease stage-specific, and thus this profile, or perhaps individual GPCRs, are potential biomarkers and therapeutic targets for CLL," said Insel. "GPCRs are attractive targets since they are expressed on the cell surface and vary in their expression in different tissues."
The researchers found that the expression of one GPCR, the vasoactive intestinal polypeptide receptor 1 (VIPR1), increased more than 700-fold in aggressive CLL compared to its expression in patients with indolent CLL. In addition, treating the leukemic cells with VIP, which activates VIPR1, induced their death.
"We find that the expression of specific GPCRs appears to a play a role in prognosis of CLL," said Dr. Insel. "Thus, such GPCRs may also provide new ways to treat the disease, since they reflect part of its underlying biology and pathology. We are undertaking other studies to determine if particular patterns of GPCR expression and perhaps that of uniquely expressed GPCRs characterize other cancers and other diseases."
###
About Experimental Biology 2012
Experimental Biology is an annual gathering of six scientific societies that this year is expected to draw 13,000-plus independent scientists and exhibitors. The societies represented are: American Association of Anatomists (AAA), American Physiological Society (APS), American Society for Biochemistry and Molecular Biology (ASBMB), American Society for Investigative Pathology (ASIP), American Society for Nutrition (ASN) and the American Society for Pharmacology and Experimental Therapeutics (ASPET).
About ASPET
ASPET is a 5,100 member scientific society whose members conduct basic and clinical pharmacological research within the academic, industrial and government sectors. Our members discover and develop new medicines and therapeutic agents that fight existing and emerging diseases, as well as increase our knowledge regarding how therapeutics affects humans.
END
San Diego, CA — Oregano, the common pizza and pasta seasoning herb, has long been known to possess a variety of beneficial health effects, but a new study by researchers at Long Island University (LIU) indicates that an ingredient of this spice could potentially be used to treat prostate cancer, the second leading cause of cancer death in American men.
Prostate cancer is a type of cancer that starts in the prostate gland and usually occurs in older men. Recent data shows that about 1 in 36 men will die of prostate cancer. Estimated new cases and deaths from this disease ...
Dr. Sandeep Jejurikar says a newly approved silicone-gel-filled breast implant increases the variety of implants available to patients, and he explains the breast augmentation options available at his plastic surgery practice near Chicago.
The new implant is approved by the U.S. Food and Drug Administration (FDA) for female breast augmentation patients age 22 and older and for female breast reconstruction patients of any age.
"It's great to see how safe choices for plastic surgery procedures are expanding," Dr. Jejurikar says. "Safety is the most ...
PROVIDENCE, R.I. [Brown University] — Here's an anatomical packing list for making that historic trip from water to land circa 370 million years ago: Lungs? Check. Legs? Check. Patches of highly vascular bone in the skin? In a new paper, scientists propose why many of the earliest four-legged creatures that dared breathe on land carried bony skin features.
The "dermal bones" within the skin, especially the bones covering the skull roof and forming part of the shoulder girdle, had a highly complex surface of ridges and furrows called "dermal sculpture." The authors suggest ...
Dr. Anna Petropoulos of The New England Facial & Cosmetic Surgery Center says changes she has seen in her Boston area BOTOX Cosmetic patients support the findings of a study recently published in the Journal of Psychiatric Research.
The study found a positive correlation between the use of botulinum toxin to treat the glabellar region of the face and a temporary reduction in depression.
Dr. Petropoulos says she sees similar results in some of her patients who receive treatment with BOTOX in the Boston area.
"BOTOX, which was the first FDA-approved medication ...
UPTON, NY - Detailed studies of one of the best-performing organic photovoltaic materials reveal an unusual bilayer lamellar structure that may help explain the material's superior performance at converting sunlight to electricity and guide the synthesis of new materials with even better properties. The research, published in Nature Communications April 24, 2012, was conducted by scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, in collaboration with researchers from Stony Brook University, Seoul National University in Korea, the Max Planck ...
STANFORD, Calif. — Stanford University School of Medicine neuroscientists have demonstrated, in a study to be published online April 24 in Stroke, that a compound mimicking a key activity of a hefty, brain-based protein is capable of increasing the generation of new nerve cells, or neurons, in the brains of mice that have had strokes. The mice also exhibited a speedier recovery of their athletic ability.
These results are promising, because the compound wasn't administered to the animals until a full three days after they had suffered strokes, said the study's senior ...
Etna Interactive, a dynamic Web services firm, will be a featured exhibitor at The Aesthetic Meeting 2012 in Vancouver.
During The American Society for Aesthetic Plastic Surgery (ASAPS) meeting, May 5-8 at the Vancouver Convention Center, board-certified plastic surgeons from around the world will engage with industry-related companies about their products and services.
As a special bonus, Etna Interactive will be offering free half-hour website assessments, personalized Web marketing advice and a show guide handout with helpful tips for choosing reliable Web marketing ...
PROVIDENCE, R.I. [Brown University] — Because a function of RNA is to be translated as the genetic instructions for the protein-making machinery of cells, RNA editing is the body's way of fine-tuning the proteins it produces, allowing us to adapt. The enzyme ADAR, which does this editing job in the nervous system of creatures ranging from mice to men, even edits itself. In a new study that examined the self-editing process and locked it down at two extremes in fruit flies, Brown University scientists found some surprising insights into how this "fine-tuning of the fine-tuner" ...
As part of their commitment to providing useful information in plain English, specialist niche insurance broker Cover4caravans.co.uk have added a fun and useful infographic to their website highlighting information you may not know from the caravan universe.
For example:
- it is estimated that there are a whopping 500,000 tourers on the road in the UK- with around 15-20% not insured;
- the average cost of a claim is 19.25% more than cost of a caravan insurance policy;
- the UK's most expensive static caravan in the UK is the Haulfryn Anniversary Lodge in Wales, that ...
CHICAGO – A text messaging intervention with education-related messages sent to parents increased influenza vaccination coverage compared with usual care in a traditionally hard-to-reach, low-income, urban, minority population of children and adolescents, although coverage overall remained low, according to a study in the April 25 issue of JAMA.
"Timely vaccination is the cornerstone of influenza prevention through vaccination of susceptible populations before illness becomes epidemic in communities. The effectiveness of the influenza vaccine in children and adolescents ...
